Sfoglia per Autore
DIFFERENTIATING MUSCLE REQUIRES EARLY COORDINATED CHANGES IN MITOCHONDRIAL DYNAMICS : NITRIC OXIDE AS TASKMASTER OF DRP-1 ACTIVITY AND LOCALIZATION
2007 S. Falcone, C. De Palma, S. Pisoni, S. Cheli, S. Brunelli, L. Scorrano, E. Clementi
Intra-chromosomal looping within FSHD locus provides the epigenitic link between D4Z4 array and FRG1 gene expression
2008 B. Bodega, G.A. DI CAPUA, S. Cheli, F. Grasser, S. Mueller, A. Marozzi, E. Battaglioli, E. Ginelli
Remodeling of the chromatin structure of the facioscapulohumeral muscular dystrophy (FSHD) locus and upregulation of FSHD-related gene 1 (FRG1) expression during human myogenic differentiation
2009 B. Bodega, G. Di Capua, F. Grasser, S. Cheli, S. Brunelli, M. Mora, R. Meneveri, A. Marozzi, S. Mueller, E. Battaglioli, E. Ginelli
LINEE CELLULARI DERIVATE DA PAZIENTI AFFETTI DA DISTROFIA FACIO-SCAPOLO-OMERALE (FSHD) DI TIPO 1 E 2 MOSTRANO LUNGO IL DIFFERENZIAMENTO MIOGENICO PROFILI DIVERSI DI ESPRESSIONE GENICA.
2010 S. Cheli
Autophagy as a new therapeutic target in Duchenne muscular dystrophy
2012 C. De Palma, F. Morisi, S. Cheli, S. Pambianco, V. Cappello, M. Vezzoli, P. Rovere Querini, M. Moggio, M. Ripolone, M. Francolini, M. Sandri, E. Clementi
ACE inhibitors and ribavirin-associated cough: a common undefined predisposing factor?
2013 L. Milazzo, D. Cattaneo, S. Cheli, L. Ferraris, E. Colella, E.G.I. Clementi, C. Gervasoni
Levofloxacin-induced seizures in a patient without predisposing risk factors : the impact of pharmacogenetics
2013 C. Gervasoni, D. Cattaneo, F.S. Falvella, P. Vitiello, S. Cheli, L. Milazzo, E. Clementi, A. Riva
ITPA and SLC29A1 Genotyping for the Prediction of Ribavirin Dose Reduction in Anti-HCV Triple Therapy with Protease Inhibitors
2015 A. Lombardi, S. Landonio, C. Magni, S. Cheli, C. Mazzali, M.U. Mondelli, G. Rizzardini, E. Clementi, F.S. Falvella
Undetected toxicity risk in pharmacogenetic testing for dihydropyrimidine dehydrogenase
2015 F.S. Falvella, M. Caporale, S. Cheli, A. Martinetti, R. Berenato, C. Maggi, M. Niger, F. Ricchini, I. Bossi, M. Di Bartolomeo, E. Sottotetti, F.F. Bernardi, F. de Braud, E. Clementi, F. Pietrantonio
LightSNiP assay is a good strategy for pharmacogenetics test
2015 S. Cheli, F. Pietrantonio, E. Clementi, F.S. Falvella
SLC29A1 polymorphism and prediction of anaemia severity in patients with chronic hepatitis C receiving triple therapy with telaprevir
2015 L. Milazzo, A.M. Peri, C. Mazzali, C. Magni, E. Calvi, A. De Nicolò, E. Clementi, S. Cheli, A. D'Avolio, S. Antinori, F.S. Falvella
DPD and UGT1A1 deficiency in colorectal cancer patients receiving triplet chemotherapy with fluoropyrimidines, oxaliplatin and irinotecan
2015 F.S. Falvella, S. Cheli, A. Martinetti, C. Mazzali, R. Iacovelli, C. Maggi, M. Gariboldi, M.A. Pierotti, M. Di Bartolomeo, E. Sottotetti, R. Mennitto, I. Bossi, F. de Braud, E. Clementi, F. Pietrantonio
The role of Toll-like receptor 4 polymorphisms in vaccine immune response
2016 P. Pellegrino, F.S. Falvella, S. Cheli, C. Perrotta, E. Clementi, S. Radice
Variant alleles in factor V, prothrombin, plasminogen activator inhibitor-1, methylenetetrahydrofolate reductase and risk of thromboembolism in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab
2016 F.S. Falvella, C. Cremolini, R. Miceli, F. Nichetti, S. Cheli, C. Antoniotti, G. Infante, A. Martinetti, F. Marmorino, E. Sottotetti, R. Berenato, M. Caporale, A. Colombo, F. de Braud, M. Di Bartolomeo, E. Clementi, F. Loupakis, F. Pietrantonio
Pharmacogenetic approach to losartan in Marfan patients : A starting point to improve dosing regimen?
2016 F.S. Falvella, S. Marelli, S. Cheli, S. Montanelli, F. Viecca, L. Salvi, A. Ferrara, E. Clementi, G. Trifirò, A. Pini
Renal function in HIV/HBV co-infected and HBV mono-infected patients on a long-term treatment with tenofovir in real life setting
2017 L. Milazzo, C. Gervasoni, F.S. Falvella, D. Cattaneo, C. Mazzali, P. Ronzi, F. Binda, S. Cheli, S. Sollima, S. Antinori
The combination of pharmacogenetic and pharmacokinetic analyses to optimize clomipramine dosing in major depression : a case report
2017 S. Antoniazzi, A. Tatulli, F.S. Falvella, M. Cigliobianco, R.A. Paoli, D. Cattaneo, S. Cheli, F.F. Bernardi, E. Clementi, C.A. Altamura
HLA-B*57: 01 testing : Care in interpreting the quality of different genotyping methods
2017 F.S. Falvella, S. Cheli, E. Clementi
Clinical and genetic determinants of nevirapine plasma trough concentration
2018 A. Giacomelli, S. Rusconi, F.S. Falvella, M.L. Oreni, D. Cattaneo, V. Cozzi, G. Renisi, E. Monge, S. Cheli, E. Clementi, A. Riva, M. Galli, A.L. Ridolfo
Different effects of glucocorticoids on darunavir plasma concentrations
2019 D. Cattaneo, S. Cheli, M. Fusi, E. Clementi, C. Gervasoni
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile